SARM1 and TRAF6 bind to and stabilize PINK1 on depolarized mitochondria

Molecular Biology of the Cell

Volumn 24, Issue 18, 2013, Pages 2772-2784

  Murata, Hitoshi ^a   Sakaguchi, Masakiyo ^a   Kataoka, Ken ^b   Huh, Nam Ho ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; PARKIN; STERILE ALPHA AND TIR MOTIF CONTAINING 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MITOCHONDRION; MITOPHAGY; OUTER MEMBRANE; PRIORITY JOURNAL; UBIQUITINATION;

ARMADILLO DOMAIN PROTEINS; CYTOSKELETAL PROTEINS; HEK293 CELLS; HELA CELLS; HUMANS; LYSINE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIA; PROTEIN BINDING; PROTEIN KINASES; PROTEIN STABILITY; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; TNF RECEPTOR-ASSOCIATED FACTOR 6; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84884494185     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-01-0016     Document Type: Article

References (65)

1. Abeliovich A, Flint Beal M (2006). Parkinsonism genes: culprits and clues. J Neurochem 99, 1062-1072. (Pubitemid 44655273)
2. Beilina A, Van Der Brug M, Ahmad R, Kesavapany S, Miller DW, Petsko GA, Cookson MR (2005). Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci USA102, 5703-5708. (Pubitemid 40559623)
3. Belinda LW, Wei WX, Hanh BT, Lei LX, Bow H, Ling DJ (2008). SARM: a novel Toll-like receptor adaptor, is functionally conserved from arthropod to human. Mol Immunol 45, 1732-1742. (Pubitemid 351221135)
4. Bonifati V et al. (2003). Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259. (Pubitemid 36131051)
5. Bonifati V et al. (2005). Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 65, 87-95. (Pubitemid 40967781)
6. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV (1996). TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446. (Pubitemid 26330834)
7. Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, Hess S, Chan DC (2011). Broad activation of the ubiquitin-proteasome system by parkin is critical for mitophagy. Hum Mol Genet 20, 1726-1737.
8. Chang C, Hsieh YW, Lesch BJ, Bargmann CI, Chuang CF (2011). Microtubule-based localization of a synaptic calcium-signaling complex is required for left-right neuronal asymmetry in C. elegans. Development 138, 3509-3518.
9. Chen CY, Lin CW, Chang CY, Jiang ST, Hsueh YP (2011). Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology. J Cell Biol 193, 769-784.
10. Chuang CF, Bargmann CI (2005). A Toll-interleukin 1 repeat protein at the synapse specifies asymmetric odorant receptor expression via ASK1 MAPKKK signaling. Genes Dev 19, 270-281. (Pubitemid 40111122)
11. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162-1166. (Pubitemid 43990738)
12. Criscuolo C et al. (2006). PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. Mov Disord 21, 1265-1267. (Pubitemid 44336626)
13. Dalod M (2007). Studies of SARM1 uncover similarities between immune and neuronal responses to danger. Sci STKE 2007, pe73.
14. Deas E et al. (2011). PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet 20, 867-879.
15. Deng H, Jankovic J, Guo Y, Xie W, Le W (2005). Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun 337, 1133-1138. (Pubitemid 41505244)
16. Gandhi S et al. (2006). PINK1 protein in normal human brain and Parkinson's disease. Brain 129, 1720-1731. (Pubitemid 43999406)
17. Gegg ME, Cooper JM, Chau KY, Rojo M, Schapira AH, Taanman JW (2010). Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum Mol Genet 19, 4861-4870.
18. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W (2010). PINK1/parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12, 119-131.
19. Glauser L, Sonnay S, Stafa K, Moore DJ (2011). Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. J Neurochem 118, 636-645.
20. Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, McBride HM, Park DS, Fon EA (2012). Mitochondrial processing peptidase regulates PINK1 processing, import and parkin recruitment. EMBO Rep 13, 378-385.
21. Haque ME, Thomas KJ, D'Souza C, Callaghan S, Kitada T, Slack RS, Fraser P, Cookson MR, Tandon A, Park DS (2008). Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci USA105, 1716-1721. (Pubitemid 351346580)
22. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A (2006). Genetics of Parkinson's disease and parkinsonism. Ann Neurol 60, 389-398. (Pubitemid 44684974)
23. Hattori N, Mizuno Y (2004). Pathogenetic mechanisms of parkin in Parkinson's disease. Lancet 364, 722-724. (Pubitemid 39140630)
24. Hofmann RM, Pickart CM (1999). Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 96, 645-653. (Pubitemid 29122807)
25. Hsu H, Shu HB, Pan MG, Goeddel DV (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308. (Pubitemid 26042835)
26. Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ (2010). Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 191, 933-942.
27. Kessler KR, Hamscho N, Morales B, Menzel C, Barrero F, Vives F, Gispert S, Auburger G (2005). Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson's syndrome. J Neural Transm 112, 1345-1353. (Pubitemid 41355962)
28. Kim Y, Zhou P, Qian L, Chuang JZ, Lee J, Li C, Iadecola C, Nathan C, Ding A (2007). MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival. J Exp Med 204, 2063-2074. (Pubitemid 47360869)
29. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608. (Pubitemid 28207717)
30. Kondapalli C et al. (2012). PINK1 is activated by mitochondrial membrane potential depolarization and stimulates parkin E3 ligase activity by phosphorylating serine 65. Open Biol 2, 120080.
31. Lamothe B, Besse A, Campos AD, Webster WK, Wu H, Darnay BG (2007). Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J Biol Chem 282, 4102-4112. (Pubitemid 47084488)
32. Lazarou M, Jin SM, Kane LA, Youle RJ (2012). Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase parkin. Dev Cell 22, 320-333.
33. Lee HJ, Jang SH, Kim H, Yoon JH, Chung KC (2012). PINK1 stimulates interleukin-1beta-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1. Cell Mol Life Sci 69, 3301-3315.
34. Liberati NT, Fitzgerald KA, Kim DH, Feinbaum R, Golenbock DT, Ausubel FM (2004). Requirement for a conserved Toll/interleukin-1 resistance domain protein in the Caenorhabditis elegans immune response. Proc Natl Acad Sci USA101, 6593-6598. (Pubitemid 38586019)
35. Mansell A, Brint E, Gould JA, O'Neill LA, Hertzog PJ (2004). Mal interacts with tumor necrosis factor receptor-associated factor (TRAF)-6 to mediate NF-kappaB activation by toll-like receptor (TLR)-2 and TLR4. J Biol Chem 279, 37227-37230. (Pubitemid 39195427)
36. Matsuda N et al. (2010). PINK1 stabilized by mitochondrial depolarization recruits parkin to damaged mitochondria and activates latent parkin for mitophagy. J Cell Biol 189, 211-221.
37. Meijer AH, Gabby Krens SF, Medina Rodriguez IA, He S, Bitter W, Ewa Snaar-Jagalska B, Spaink HP (2004). Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish. Mol Immunol 40, 773-783. (Pubitemid 37542427)
38. Meissner C, Lorenz H, Weihofen A, Selkoe DJ, Lemberg MK (2011). The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J Neurochem 117, 856-867.
39. Mink M, Fogelgren B, Olszewski K, Maroy P, Csiszar K (2001). A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo/beta-catenin that is conserved in mouse, Drosophila, and Caenorhabditis elegans. Genomics 74, 234-244. (Pubitemid 32550145)
40. Mukhopadhyay D, Riezman H (2007). Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315, 201-205. (Pubitemid 46166358)
41. Muqit MM et al. (2006). Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem 98, 156-169. (Pubitemid 43882941)
42. Murata H, Sakaguchi M, Jin Y, Sakaguchi Y, Futami J, Yamada H, Kataoka K, Huh NH (2011a). A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J Biol Chem 286, 7182-7189.
43. Murata H, Sakaguchi M, Kataoka K, Huh NH (2011b). Multiple functions of PINK1 at different intracellular locations: beyond neurodegenerative diseases. Cell Cycle 10, 1518-1519.
44. Nakajima A, Kataoka K, Hong M, Sakaguchi M, Huh NH (2003). BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential. Cancer Lett 201, 195-201. (Pubitemid 37357169)
45. Narendra D, Tanaka A, Suen DF, Youle RJ (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183, 795-803.
46. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ (2010). PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8, e1000298.
47. O'Neill LA, Bowie AG (2007). The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7, 353-364. (Pubitemid 46674493)
48. Okatsu K et al. (2012). PINK1 autophosphorylation upon membrane potential dissipation is essential for parkin recruitment to damaged mitochondria. Nat Commun 3, 1016.
49. Osterloh JM et al. (2012). dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337, 481-484.
50. Panneerselvam P, Singh LP, Ho B, Chen J, Ding JL (2012). Targeting of pro-apoptotic TLR adaptor SARM to mitochondria: definition of the critical region and residues in the signal sequence. Biochem J 442, 263-271.
51. Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J (2006). Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157-1161. (Pubitemid 43990737)
52. Polymeropoulos MH et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047. (Pubitemid 27443610)
53. Poole AC, Thomas RE, Yu S, Vincow ES, Pallanck L (2010). The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One 5, e10054.
54. Rakovic A, Grunewald A, Kottwitz J, Bruggemann N, Pramstaller PP, Lohmann K, Klein C (2011). Mutations in PINK1 and parkin impair ubiquitination of mitofusins in human fibroblasts. PLoS One 6, e16746.
55. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, Casari G (2005). Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14, 3477-3492. (Pubitemid 41672130)
56. Strauss KM et al. (2005). Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 14, 2099-2111. (Pubitemid 41418010)
57. Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, Youle RJ (2010). Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by parkin. J Cell Biol 191, 1367-1380.
58. Valente EM et al. (2004). Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160. (Pubitemid 38661852)
59. Vives-Bauza C et al. (2010). PINK1-dependent recruitment of parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA 107, 378-383.
60. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ (2001). TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351. (Pubitemid 32694385)
61. Wu H, Arron JR (2003). TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 25, 1096-1105. (Pubitemid 37411769)
62. Ye H, Park YC, Kreishman M, Kieff E, Wu H (1999). The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 4, 321-330. (Pubitemid 29499785)
63. Yoshii SR, Kishi C, Ishihara N, Mizushima N (2011). Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem 286, 19630-19640.
64. Zimprich A et al. (2004). Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607. (Pubitemid 39531225)
65. Ziviani E, Tao RN, Whitworth AJ (2010). Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc Natl Acad Sci USA107, 5018-5023. Technology